FP7H2020
Gabo:mi Gesellschaft Fur Ablauforganisation:milliarium Mbh & Co KG
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 54
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 11,886,842
- Active
- 2008 to 2016
Projects
54 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| WAKE-UPEfficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial | FP7 | 2011 | Participant | EUR 209,458 |
| ONCOTRACKOncoTrack - Methods for systematic next generation oncology biomarker development | FP7 | 2011 | Participant | EUR 618,423 |
| EUROSKINGRAFTA novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects | FP7 | 2011 | Participant | EUR 209,920 |
| THE HIP TRIALManagement of Hypotension In the Preterm Extremely Low Gestational Age Newborn | FP7 | 2010 | Participant | EUR 305,004 |
| INTRICATEInfectious triggers of chronic autoimmunity | FP7 | 2010 | Participant | EUR 422,469 |
| NEMOTreatment of NEonatal seizures with Medication Off-patent: evaluation of efficacy and safety of bumetanide | FP7 | 2009 | Participant | EUR 367,800 |
| NEWMEDSNovel Methods leading to New Medications in Depression and Schizophrenia | FP7 | 2009 | Participant | EUR 564,810 |
| SICA-HFStudies Investigating Co-morbidities Aggravating Heart Failure | FP7 | 2009 | Participant | EUR 177,960 |
| CARDIORISKThe mechanisms of cardiovascular risks after low radiation doses | FP7 | 2008 | Participant | EUR 112,400 |
| EURIPIDESEUropean Research initiative to develop Imaging Probes for early In-vivo Diagnosis and Evaluation of response to therapeutic Substances | FP7 | 2008 | Participant | EUR 495,912 |
| OSPI-EUROPEOptimizing suicide prevention programs and their implementation in Europe | FP7 | 2008 | Participant | EUR 294,576 |
| BETAIMAGEUse of innovative strategies for beta-cell imaging in diabetes mellitus | FP7 | 2008 | Participant | EUR 355,458 |
| EURODSDInvestigation of the molecular pathogenesis and pathophysiology of Disorders of Sex Development (DSD) | FP7 | 2008 | Participant | EUR 257,999 |
| ARISEAffording Recovery In Stroke | FP7 | 2008 | Participant | EUR 505,500 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.